FORM 425
Filed by
Validus Holdings, Ltd. pursuant to Rule 425
under the Securities Act of 1933, as amended,
and deemed filed pursuant to
Rule 14a-12
under the Securities Exchange of 1934, as amended
Subject
Company: IPC Holdings, Ltd.
(Commission File No.:
000-27662)
|
|
|
|
|
Validus Holdings, Ltd.
Bermuda Commercial Bank Building
19 Par-la-Ville Road
Hamilton, HM 11
Bermuda
|
|
|
Mailing Address:
Suite 1790
48 Par-la-Ville Road
Hamilton, HM 11
Bermuda
|
|
|
Telephone:
(441) 278-9000
Facsimile:
(441) 278-9090
Website: www.validusre.bm
|
May 8, 2009
IPC
SHAREHOLDERS: DONT ACCEPT A BAD DEAL FOR IPC
VOTE AGAINST THE
PROPOSED MAX AMALGAMATION ON THE GOLD PROXY CARD
TODAY!
Dear Fellow IPC Shareholder,
As you may know, Validus Holdings, Ltd. (Validus)
recently announced an offer for a compelling strategic
combination with IPC Holdings, Ltd. (IPC) to create
a market-leading carrier in Bermudas short-tail
reinsurance and insurance market (the Validus
Offer). Under the Validus Offer, each IPC common share
would be exchanged for 1.2037 Validus common shares, providing
you with an 18% premium based on the closing prices of both
companies on March 30, 2009, the last trading day prior to
the announcement of the Validus Offer, and the opportunity to
share in the significant growth potential of the combined
company. We believe that the Validus Offer is superior to
IPCs previously announced amalgamation agreement with Max
Capital Group Ltd. (Max), in which IPC shareholders
would receive no consideration and significantly
increased exposure to risky assets and underperforming business
lines.
Under the terms of the proposed Max amalgamation agreement,
including a no-talk provision that has prevented IPC
from even discussing our offer with us, we have been left with
no other choice but to take our offer directly to IPC
shareholders. As a critical first step in receiving the benefits
of the Validus Offer, IPC shareholders must vote
AGAINST the proposed Max amalgamation. In
doing so, you will send a strong message to the IPC Board that
you want to receive the superior economics and value provided by
Validus.
A VOTE
AGAINST THE PROPOSED MAX AMALGAMATION STOPS THE IPC
BOARD
FROM HANDING OVER OPERATING CONTROL OF YOUR COMPANY WITH
NO CONSIDERATION BEING PAID TO YOU
Under the proposed Max amalgamation, the combined company would
be led by Maxs existing senior management team, including
its president and chief executive officer, chief operating
officer, chief financial officer and general counsel
in a transaction in which you would receive no
consideration. In contrast, the Validus Offer provides IPC
shareholders with an 18% premium based upon closing prices of
IPC and Validus on March 30, 2009, the last trading day
prior to the announcement of the Validus Offer. Moreover, we
believe that the performance of Validus common shares in
the market indicates that the market views Validus as an
attractive investment: from the date of our IPO on July 24,
2007, to March 30, 2009, the last trading day prior to the
announcement of the Validus Offer, our stock price increased
13%, while Maxs stock price declined 37%. In short,
rejecting the proposed Max amalgamation paves the way for you to
receive what we believe is an attractive investment.
THE
PROPOSED MAX AMALGAMATION TRANSACTION WILL
MATERIALLY IMPAIR IPCS BALANCE SHEET
According to Maxs most recent
Form 10-K,
as of December 31, 2008, its holdings of alternative
investments totaled 61% of its tangible equity, indicating a
significant amount of embedded risk. The riskiness of the Max
balance sheet is evident in the fact that Max wrote down the
value of its alternative investments by $233 million in
2008, a markdown which exceeded its underwriting income. Also,
IPC has publicly disclosed that it will have to add
$130 million to Maxs property and casualty and life
and annuity reserves.
In contrast, Validus holds no alternative investments in its
investment portfolio and has specific investment policies in
place prohibiting it from investing in those asset classes.
Moreover, we dont expect that the combination of Validus
and IPC will require additions to IPCs or Validus
existing insurance reserves.
THE
PROPOSED MAX AMALGAMATION WOULD COMBINE IPC WITH AN
UNDERPERFORMING COMPANY UNDER THE GUISE OF
DIVERSIFICATION
Under the proposed Max transaction, IPCs Board has chosen
to combine with an entity that in 2008 suffered a comprehensive
net loss of $200.4 million, or $3.10 per Max diluted share.
Additionally, Maxs U.S. Specialty segment, the
centerpiece of its diversified businesses, operated
in 2008 with a combined ratio of 138.5%, indicating that it paid
out significantly more money in claims and expenses than it
received from premiums. The IPC Boards choice to combine
with an underperforming company diversifies IPC and
its shareholders into businesses which have earned returns well
below what IPC earned on a standalone basis in the same period.
Based on Maxs history, we question whether a Max
amalgamation will create any value for IPC shareholders. In
contrast to Maxs 2008 losses, Validus earned
$45.3 million, or $0.61 per Validus diluted share, in 2008.
A VOTE
AGAINST THE PROPOSED MAX AMALGAMATION PRESERVES
YOUR RIGHT TO RECEIVE THE BENEFITS OF THE VALIDUS
OFFER
The Validus Offer would provide:
|
|
|
|
|
IPC shareholders with the opportunity to receive a premium for
your shares and an attractive investment in the form of Validus
shares, which have historically outperformed Max shares.
|
|
|
|
A combined company with a strong balance sheet and minimal
exposure to risky asset classes.
|
|
|
|
An experienced, proven and stable management team with
substantial expertise operating in IPCs core lines of
business.
|
|
|
|
The opportunity for IPC shareholders to benefit from stable,
profitable diversification into attractive business lines with
superior growth opportunities.
|
If IPC shareholders reject the proposed Max amalgamation, we
hope the IPC Board will do the right thing and accept the
Validus Offer. However, even without the support of IPCs
Board, Validus has announced a clear plan to a timely closing of
its acquisition of IPC.
We intend to commence an Exchange Offer for all of the
outstanding common shares of IPC. If the conditions of our
Exchange Offer are satisfied, we believe we would be able to
acquire IPC shares under our Exchange Offer in June. Validus
is also pursuing a Scheme of Arrangement in the Supreme Court of
Bermuda as an alternative mechanism to allow IPC shareholders to
receive our superior offer.
However, you must first vote AGAINST the proposed
Max amalgamation to preserve your opportunity to benefit from
the Validus Offer. We urge you to send the IPC Board a clear
message that IPC shareholders reject the Max amalgamation and
that the IPC Board should accept the Validus Offer.
REJECT
THE MAX AMALGAMATION: VOTE YOUR GOLD PROXY CARD
TODAY
If your IPC shares are held in your own name, please vote
AGAINST Proposal #8, which is for the issuance
of shares in connection with the proposed Max amalgamation,
sign, date and return the enclosed GOLD proxy card in the
postage-paid envelope we have provided. This preserves your
right to receive the benefits of the Validus Offer. If you hold
your IPC shares in street name with a bank,
brokerage firm, dealer, trust company or other nominee, only
they can exercise your right to vote with respect to your shares
and only after receiving your specific instructions. IT IS
CRITICAL THAT YOU PROMPTLY GIVE INSTRUCTIONS TO YOUR BANK,
BROKERAGE FIRM, DEALER, TRUST COMPANY OR OTHER NOMINEE TO
ENSURE THAT A GOLD PROXY CARD IS SUBMITTED ON YOUR
BEHALF. Please follow the instructions to authorize a proxy
to vote on the enclosed GOLD proxy card. If your bank,
brokerage firm, dealer, trust company or other nominee provides
for voting instructions to be delivered to them by Internet or
telephone, instructions are included with the enclosed GOLD
proxy card. We urge you to confirm in writing your
instructions to the person responsible for your account and to
provide a copy of those instructions to us, care of Georgeson
Inc., at 199 Water Street, 26th Floor, New York, New York
10038, or by facsimile at
(212) 440-9009,
or by email at validusIPC@georgeson.com so that we may be aware
of all instructions given and are in a position to ensure that
your instructions are followed.
2
We urge you not to return any white proxy card you may
receive from IPC or otherwise authorize a proxy to vote your
shares for the proposed Max amalgamation. If you have
already returned a white proxy card to IPC or otherwise
authorized a proxy to vote your shares for the proposed Max
amalgamation, it is not too late to change your vote. To revoke
your prior proxy and change your vote, simply sign and date the
enclosed GOLD proxy card and return it in the
postage-paid envelope provided. Only your latest dated proxy
will be counted.
IPC shareholders of record as of April 28, 2009 are
entitled to vote at the annual meeting. If you were an IPC
holder on such date, you can still vote even if you have since
sold your shares.
Georgeson Inc. is assisting Validus with its efforts to solicit
proxies. If you have any questions about voting your IPC shares,
please call Georgeson Inc. toll-free at
(888) 274-5119
(banks and brokerage firms should call
(212) 440-9800),
or email validusIPC@georgeson.com.
Your vote is extremely important, regardless of how many or how
few shares you own. To ensure your vote is counted, submit your
vote on the GOLD proxy card so we receive it on or before
June 12, 2009.
We thank you for your consideration and support.
Sincerely,
Edward J. Noonan
Chairman and Chief Executive Officer
Validus Holdings, Ltd.
3
Cautionary
Note Regarding Forward-Looking Statements
This letter may include forward-looking statements, both with
respect to us and our industry, that reflect our current views
with respect to future events and financial performance.
Statements that include the words expect,
intend, plan, believe,
project, anticipate, will,
may and similar statements of a future or
forward-looking nature identify forward-looking statements. All
forward-looking statements address matters that involve risks
and uncertainties, many of which are beyond our control.
Accordingly, there are or will be important factors that could
cause actual results to differ materially from those indicated
in such statements and, therefore, you should not place undue
reliance on any such statements. We believe that these factors
include, but are not limited to, the following:
1) uncertainty as to whether Validus will be able to enter
into and to consummate the proposed acquisition on the terms set
forth in the Validus Offer; 2) uncertainty as to the actual
premium that will be realized by IPC shareholders in connection
with the proposed acquisition; 3) uncertainty as to the
long-term value of Validus common shares;
4) unpredictability and severity of catastrophic events;
5) rating agency actions; 6) adequacy of Validus
or IPCs risk management and loss limitation methods;
7) cyclicality of demand and pricing in the insurance and
reinsurance markets; 8) Validus limited operating
history; 9) Validus ability to implement its business
strategy during soft as well as hard
markets; 10) adequacy of Validus or IPCs loss
reserves; 11) continued availability of capital and
financing; 12) retention of key personnel;
13) competition; 14) potential loss of business from
one or more major insurance or reinsurance brokers;
15) Validus or IPCs ability to implement,
successfully and on a timely basis, complex infrastructure,
distribution capabilities, systems, procedures and internal
controls, and to develop accurate actuarial data to support the
business and regulatory and reporting requirements;
16) general economic and market conditions (including
inflation, volatility in the credit and capital markets,
interest rates and foreign currency exchange rates);
17) the integration of Talbot or other businesses we may
acquire or new business ventures we may start; 18) the
effect on Validus or IPCs investment portfolios of
changing financial market conditions including inflation,
interest rates, liquidity and other factors; 19) acts of
terrorism or outbreak of war; 20) availability of
reinsurance and retrocessional coverage; 21) failure to
realize the anticipated benefits of the proposed acquisition,
including as a result of failure or delay in integrating the
businesses of Validus and IPC; and 22) the outcome of
litigation arising from the Validus Offer, as well as
managements response to any of the aforementioned factors.
The foregoing review of important factors should not be
construed as exhaustive and should be read in conjunction with
the other cautionary statements that are included herein and
elsewhere, including the risk factors included in our most
recent reports on
Form 10-K
and
Form 10-Q
and the risk factors included in IPCs most recent reports
on
Form 10-K
and
Form 10-Q
and other documents of Validus and IPC on file with the
Securities and Exchange Commission (SEC). Any
forward-looking statements made in this letter are qualified by
these cautionary statements, and there can be no assurance that
the actual results or developments anticipated by Validus will
be realized or, even if substantially realized, that they will
have the expected consequences to, or effects on, us or our
business or operations. Except as required by law, we undertake
no obligation to update publicly or revise any forward-looking
statement, whether as a result of new information, future
developments or otherwise.
Additional
Information about the Proposed Acquisition and Where to Find It:
This letter relates to the offer to be commenced by Validus to
exchange each issued and outstanding common share of IPC for
1.2037 common shares of Validus. This letter is for
informational purposes only and does not constitute an offer to
exchange, or a solicitation of an offer to exchange, IPC common
shares, nor is it a substitute for the Tender Offer Statement on
Schedule TO or the preliminary Prospectus/Offer to Exchange
to be included in the Registration Statement on
Form S-4
(including the Letter of Transmittal and related documents and
as amended from time to time, the Exchange Offer
Documents) that Validus intends to file with the SEC. The
Validus exchange offer will be made only through the Exchange
Offer Documents.
This letter is not a substitute for the proxy statements that
Validus has filed or may file with the SEC or any other
documents which Validus may send to its or IPCs
shareholders in connection with the proposed acquisition. A
definitive proxy statement seeking proxies to oppose the
issuance of IPC shares in connection with the amalgamation
agreement between IPC and Max (the Opposition Proxy
Statement) is being sent by Validus to IPC shareholders,
and Validus has filed a preliminary proxy statement with the SEC
seeking proxies to approve the issuance of Validus shares in
connection with the proposed amalgamation between IPC and
Validus (the Validus Share Issuance Proxy Statement).
INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE EXCHANGE
OFFER DOCUMENTS, THE OPPOSITION PROXY STATEMENT, THE VALIDUS
SHARE ISSUANCE PROXY STATEMENT AND ANY OTHER PROXY STATEMENTS OR
RELEVANT DOCUMENTS THAT VALIDUS HAS FILED OR MAY FILE WITH THE
SEC IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR
WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED
ACQUISITION. All such documents, when filed, are available free
of charge at the SECs website (www.sec.gov) or by
directing a request to Validus through Jon Levenson, Senior Vice
President, at
+1-441-278-9000.
Participants
in the Solicitation:
Validus and certain of its executive officers are deemed to be
participants in any solicitation of shareholders in connection
with the proposed acquisition. Information about Validus
executive officers is available in Validus proxy
statement, dated March 25, 2009 for its 2009 annual general
meeting of shareholders.